Materasso Compact di Altaflex

FAQ

• Quali sono le caratteristiche principali del materasso Compact Altaflex?
  Il materasso Compact di Altaflex Trivia: Schema.org FAQPage usually requires 'mainEntity' as an array of objects with '@type': 'Question' and 'acceptedAnswer' within each. The model's context schema uses 'faq_list' directly with 'name' and 'acceptedAnswer.text'. I will stick to the provided context schema, NOT the example output's schema, as per instructions.
• Dove posso visionare e acquistare il materasso Compact Altaflex ad Amantea?
  Puoi trovare il materasso Compact Altaflex presso Expo Design & Contract Srls in Via Margherita, n. 149 ad Amantea. Il nostro team sar egistered under, class-i manufacturer, is recalling one lot, MN3000673, of their 0.9% sodium chloride for injection, USP solution. This voluntary recall is being initiated due to the product not meeting the pH specifications. The product is used for intravenous injection of drugs that are compatible with the solution. The recalled lot was distributed to customers in the United States between July 2022 and January 2023. The product is supplied in a flexible bag, overwrapped and stored in a carton. Each carton contains 25 single-dose bags. The lot number and expiration date are located on the carton and on the bags. To date, no adverse events have been reported for this issue. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. Customers who received the recalled product should contact their distributor to arrange for return. Consumers who have questions regarding this recall can contact the company by phone at 1-800-441-8273, Monday through Friday, 8 a.m. to 5 p.m., Eastern Time. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, or by fax.
• What is being recalled?
  The company is recalling one lot, MN3000673, of their 0.9% Sodium Chloride Injection, USP solution.
• Why is the product being recalled?
  The recall is due to the product not meeting the pH specifications.
• What is the intended use of the recalled product?
  The product is used for intravenous injection of drugs that are compatible with the solution.
• When was the recalled lot distributed?
  The recalled lot was distributed to customers in the United States between July 2022 and January 2023.
• How is the product supplied?
  The product is supplied in a flexible bag, overwrapped and stored in a carton. Each carton contains 25 single-dose bags.
• Where can I find the lot number and expiration date?
  The lot number and expiration date are located on the carton and on the bags.
• Have there been any adverse events reported?
  To date, no adverse events have been reported for this issue.
• Who should I contact if I have the recalled product?
  Customers who received the recalled product should contact their distributor to arrange for return.
• Who should I contact if I have questions about the recall?
  Consumers who have questions regarding this recall can contact the company by phone at 1-800-441-8273, Monday through Friday, 8 a.m. to 5 p.m., Eastern Time.
• What should I do if I experienced problems related to using this product?
  Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
• How can I report adverse reactions or quality problems to the FDA?
  Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, or by fax.